Skip to content

Clinical trials

Phase 1/2 Nervous System Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Nervous System Diseases Phase: Phase 1/2 Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20102
20112
20122
20151
20162
20173
20182
20192
20202
20212
20222
20232
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting5
Recruiting4
Unknown status3
Withdrawn3
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
4D Molecular Therapeutics2
Herantis Pharma Plc.2
Amylyx Pharmaceuticals Inc.1
Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud1
AskBio France, SAS, a subsidiary of AskBio Inc.1
BBB-Therapeutics B.V.1
Banc de Sang i Teixits1
Beacon Therapeutics1
BeiGene USA, Inc.1
Calico Life Sciences LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Nervous System Diseases28
Brain Diseases10
Central Nervous System Diseases10
Neurodegenerative Diseases8
Genetic Diseases, Inborn6
Metabolic Diseases5
Neuromuscular Diseases5
Autoimmune Diseases4
Central Nervous System Neoplasms4
Movement Disorders4

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.